z-logo
Premium
RHD variants in F landers, B elgium
Author(s) -
Van Sandt Vicky S.T.,
Gassner Christoph,
Emonds MariePaule,
Legler Tobias J.,
Mahieu Sarah,
Körmöczi Günther F.
Publication year - 2015
Publication title -
transfusion
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.045
H-Index - 132
eISSN - 1537-2995
pISSN - 0041-1132
DOI - 10.1111/trf.12947
Subject(s) - genotyping , typing , allele , genetics , serology , biology , abo blood group system , genotype , antibody , gene
Background D antigen variants may be grouped into partial D , weak D , and DEL types. Cumulative phenotype frequencies of these D variants may approach 1% in certain E uropean regions. Unambiguous and quick identification of D variants is of immediate clinical relevance, with implications for transfusion strategy. Study Design and Methods A total of 628 samples with ambiguous serologic results from different immunohematology laboratories throughout the F landers region, B elgium, were genotyped using a commercially available weak D typing approach. After exclusion of detectable weak D types, molecular RHD exon scanning was performed for the remaining samples, and RHD sequencing was performed in two particular cases. Results Of all samples investigated, 424 (67.5%) were positive for weak D T ype 1, 2, or 3, and 22 cases (3.5%) typed weak D T ype 4.0/4.1/4.3, 4.2, 5, 11, 15, or 17. Another 49 (7.8%) samples were partial D variants, with a major proportion being category DVI types (n = 27). One RHD ( S103P ) sample was identified as high‐grade partial D , with DIII ‐like phenotype and anti‐ D and anti‐ C immunization. Additionally, a novel DVI T ype 3 ( A399T ) variant was found. Of the remaining 133 samples mainly tested because of ambiguous serologic D typing results due to recent transfusion, 32 (5.1%) were negative for RHD , and 101 (16.1%) were indistinguishable from wild‐type RHD and not investigated further. Conclusion Despite the enormous diversity of RHD alleles, first‐line weak D genotyping was remarkably informative, allowing for rapid classification of most samples with conspicuous RhD phenotype in F landers. The clinical implications are discussed.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom